EPEva Pape

Eva Pape

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eva Pape has a total of 93 co-authors. Here are the top co-authors by number of shared publications:

  • A. Van Hecke

    Department of Public Health and Primary Care, University Centre for Nursing and Midwifery, Ghent University, Ghent, Belgium; Staff Member Nursing Department, Ghent University Hospital, Ghent, Belgium

    4 shared publications
  • Gabrielle H. van Ramshorst

    Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium

    4 shared publications
  • Gabrielle H. van Ramshorst

    Department of Human Structure and Repair, Ghent University, Ghent, Belgium

    4 shared publications
  • Y. Van Nieuwenhove

    Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium

    4 shared publications
  • Yves Van Nieuwenhove

    4 shared publications
  • Ann Van Hecke

    Staff Member Nursing Department, Ghent University Hospital, Ghent, Belgium; Department of Public Health and Primary Care, University Centre for Nursing and Midwifery, Ghent University, Ghent, Belgium

    3 shared publications

Latest Publications

  • Development and Content Validation of a Belgian Patient Decision Aid for Surgical Decision-making in Rectal Cancer: A Double-modified Delphi Study

    by Isabel Vlerick, Gabriëlle H. van Ramshorst, Dirk Van de Putte, Karen Geboes, Wim Ceelen, Ann Van Hecke, Yves Van Nieuwenhove, Eva Pape

  • Experiences of LGB patients undergoing colorectal cancer surgery: A focus on sexuality

    by Anna Provoost, Louis Onghena, Khushi Jeswani, Yves van Nieuwenhove, Eva Pape, Gabrielle H. van Ramshorst

    Purpose: This study aimed to delineate the existing knowledge regarding the impact of colorectal cancer surgery on the sexuality of LGB patients, highlighting the need for culturally competent care tailored to their unique needs. Methods: A comprehensive search was conducted from October 2024 onwards across PubMed, Embase, CINAHL, Google Scholar, Web of Science, Scopus, PsychINFO, Cochrane Library, and Joanna Briggs Institute using the MeSH terms ‘sexual and gender minorities’, ‘colorectal surgery’, ‘colorectal neoplasms’ and ‘sexuality’. Inclusion criteria required LGB patients over 18 years, at least 50% of the sample diagnosed with colorectal cancer and treated operatively. All studies were critically appraised. Results: Six studies from the UK and the US were included. Sample size ranged from 1 to 480. Participants identifying as LGB ranged from 26.4 to 100%. Key findings revealed LGB patients experience similar physical consequences to heterosexual patients (erectile and ejaculatory dysfunction, dyspareunia, vaginal dryness), but implications might differ, e.g., regarding anal intercourse. A lower mental quality of life was reported, including body image issues related to stomas. Relationship challenges and intimacy issues were highlighted. The cultural competence of healthcare providers has a significant influence on patient experiences, highlighting a gap in inclusive care. Critical appraisal revealed both methodological strengths and weaknesses. Conclusion: This review highlighted the sexual health challenges of LGB patients after colorectal cancer surgery, with issues like sexual function and mental wellbeing often being underreported. Cultural competence training for healthcare providers and integrating patients' partners into cancer care are crucial for a holistic approach.

  • Sexual health of LGBTQ + patients undergoing colorectal surgery for benign disease and their experience with healthcare: A scoping review

    by Zoe Marangoni, Louis Onghena, Maddalena Giacomozzi, Yves van Nieuwenhove, Eva Pape, Gabrielle H. van Ramshorst

    Introduction: Colorectal surgery for benign indications affects patients' sexual health. LGBTQ+ patients often face discrimination, resulting in unmet health needs. We aimed to investigate how colorectal surgery for benign disease affects LGBTQ+ individuals' sexual health, and which barriers exist to access healthcare. Methods: PubMed, Embase, Web of Science, Scopus, PsychINFO, Google Scholar, CINHAL, ProQuest, Cochrane library and Joanna Briggs Institute were systematically searched. Screening and data extraction were performed independently by two researchers. Inclusion criteria were adult patients who self‐identified as LGBTQ+; colorectal or anal procedures for benign disease; outcomes of sexual health/wellbeing/pleasure. Exclusion criteria were appendicectomy, transrectal procedures or gender‐affirming surgery and >50% of patients treated for malignancy. Results: Of the 719 records, eight articles were selected: one prospective cohort study, three mixed‐methods surveys and four literature reviews. Ten main themes were identified: sexual function/activity and pain, anoreceptive intercourse (ARI), sexual satisfaction and pleasure, mental health and body image, obstacles and coping strategies, dating and relationships, partner response and inclusion, experience with healthcare providers, information sources, stigma and discrimination. Colorectal surgery negatively impacts sexual health and relationships. LGBTQ+ patients reported challenges in accessing care and information regarding sexual health after colorectal surgery, whilst facing discrimination and stigma. Conclusion: Colorectal surgery for benign disease affects LGBTQ+ patients' sexual health. Literature is scarce, with limited data stratification for sexual orientation or gender identity. Healthcare providers need to be educated about LGBTQ+ needs relating to sexual health and surgery, and inclusive clinical guidelines should be developed.

  • Dynamics in experiences, information and counselling needs of patients without or with minor LARS after rectal cancer surgery

    by Fien Serroyen, Ann Van Hecke, Liesbet Delforge, Gabrielle H. van Ramshorst, Yves Van Nieuwenhove, Karen Geboes, Willem Lybaert, Paul H.R.L. Pattyn, Eva Pape


  • The Organisation and Implementation of Nurse‐Led Clinics: Lessons Learned From the Experiences in Five Countries

    by Marie Cerulus, Nathalie Duerinckx, Fabienne Dobbels, Pieter Heeren, Marie Dauvrin, Jens Detollenaere, Koen Van Den Heede, Eva Pape, Annemarie Coolbrandt, Theo van Achterberg, et al.

    Aim: To describe the organisation of nurse‐led clinics and the factors facilitating or hindering their implementation based on experiences in five countries. Design: Descriptive multimethod study. Methods: We analysed policy documents, nursing competency profiles and scientific literature and conducted 27 semi‐structured interviews with stakeholders from the Netherlands, Ontario, Ireland, France and Finland between April and June 2023. We summarised relevant information on nurse‐led clinic organisation in categories and mapped contextual factors following the Context and Implementation of Complex Interventions framework. Results: In the Netherlands, Ontario and France, nurse‐led clinics are implemented in all care settings. In all regions, clinics are led by nurses with varied educational backgrounds, but master‐trained advanced practice nurses have more autonomy than bachelor‐trained nurses. In France and Ireland, expanded scope of nursing practice is expected to be formally documented in a practice agreement or protocol. In all regions, nurses can prescribe medication under specific conditions. Interviewees stressed the relevance of continuous education for nurses and clear role delineation to facilitate the implementation of nurse‐led clinics and collaboration with physicians. Organisational readiness, practical support and research to demonstrate quality, safety and cost‐effectiveness of nurses' expanded roles were drivers of successful nurse‐led clinic integration. Conclusion: Nurse‐led clinics operate across various care settings and are staffed with nurses from diverse educational backgrounds, requiring adequate training and experience for autonomous practice. Successful implementation depends on clear role delineation, close collaboration with healthcare professionals, and supportive educational, legal and financial frameworks to ensure sustainable integration. Impact: Our comprehensive description of the organisation of nurse‐led clinics—including legal, financial, educational and practical aspects— along with our analysis of contextual factors supporting their implementation, provides guidance to policymakers and healthcare organisations considering the successful and sustainable adoption of this model of care within their healthcare system. Patient or Public Contribution: No Patient or Public Contribution.


  • Open Access

    Illuminating the nutrition-related policy-practice gaps in colorectal cancer survivorship

    by Kristina Vingrys, Lauren Atkins, Eva Pape, Annelie Shaw, Amanda Drury

    Purpose: Colorectal cancer (CRC) is among the three most commonly diagnosed cancers globally, after breast and lung cancer, with an estimated 2 million new cases each year, comprising ten per cent of all cancers worldwide. CRC has a complex aetiology associated with several nutrition-related risk factors. Cancer survivors frequently report alterations to their dietary habits and nutritional intake, with related adverse impacts on health-related quality of life (QOL). Whilst nutrition-related factors are recognised as survivor priorities and embedded in survivor care policies, dietary support is frequently not the standard of care in practice. Methods and results: In this Commentary, we present details of a critical policy-practice gap for CRC survivors across the spectrum of nutrition care that we have seen growing in the literature, in hospitals, community and private practice. Conclusion: As these nutrition concerns can adversely impact QOL and morbidity and mortality risks, we hope to raise awareness of these issues to provide a basis of future work in this area, so that policymakers and clinicians can improve support and outcomes for CRC survivors and their families.


  • Intervention pathways for low anterior resection syndrome after sphincter‐saving rectal cancer surgery: A systematic scoping review

    by Eva Pape, Jennie Burch, Gabrielle H. van Ramshorst, Yves van Nieuwenhove, Claire Taylor


  • Experiences of patients with cancer and their relatives confronted with COVID‐19 related delay or change in care: A qualitative study

    by Ilyse Kenis, Sofie Theys, Michiel Daem, Elsie Decoene, Veerle Demolder, Veerle Duprez, Eva Pape, Marijke Quaghebeur, Sofie Verhaeghe, Veerle Foulon, et al.

    Aims To provide in-depth insight into how patients and their relatives experienced change or delay in cancer treatment and care due to COVID-19. Design A qualitative study including semi-structured interviews with patients with cancer and their relatives. Methods Between July and October 2020, 42 patients who were confronted with a change or delay in cancer treatment or care, and 11 relatives were interviewed. Data collection and analysis were performed according to the most important methods of grounded theory, including iterative data collection and analysis, theoretical sampling, constant comparative analysis and theoretical sensitivity. Results This study shows that patients with cancer and relatives experienced paradoxical feelings when confronted with change or delay in treatment or care due to COVID-19. Patients and relatives felt relieved (e.g. less risk of infection), but were also concerned and anxious (e.g. fear for progression, fear for more side effects). Due to these ambivalent feelings, it was difficult for patients and relatives to cope with the change or delay in treatment or care, both when this was decided by the physician and by themselves. In combination with the general impact of COVID-19 on their daily lives, the change or delay led to additional distress. The interviews showed that exploring the meaning of change or delay of care for patients and their relatives and discussing what would help them might prevent or relieve distress. Conclusion The findings of our study show that COVID-19 and the associated delay or changes in cancer treatment and care had a major impact on the well-being of patients and their relatives. Person-oriented care is even more important during (emergency) situations in which care might be changed or delayed.


  • Quality of Life after Minimally Invasive Esophagectomy: A Cross-Sectional Study

    by Elke Van Daele, Eefje Stuer, Hanne Vanommeslaeghe, Wim Ceelen, Piet Pattyn, Eva Pape

    Introduction: Surgery remains essential in the curative treatment of esophageal cancer (EC), but it is known for its high morbidity and impaired health-related QoL. Minimally invasive esophagectomy (MIE) was introduced to reduce surgical trauma and improve QoL. Methods: This cross-sectional study aimed to evaluate long-term HRQoL after MIE in comparison with the general population. HRQoL assessment was based on three questionnaires: the European Organisation for Research and Treatment of Cancer (EORTC) Core 30 (QLQ-C30, version 3), the EORTC QLQ Oesophago Gastric 25 (QLQ-OG25), and the Supportive Care Needs Survey-Short Form 34 (SCNS-SF34). Results were compared to a healthy reference population. Results: One hundred and forty eligible MIE patients were identified, of whom met the inclusion criteria, and 49 completed all questionnaires. Patients reported a significantly better mean score on the global health status and QoL than the healthy reference population (71.5 ± 15.1 vs. 66.1 ± 21.7; p = 0.016). However, patients scored significantly worse about functioning (physical, role, and social) (p < 0.05), fatigue (p = 0.021), eating, dysphagia, pain and discomfort, reflux, appetite loss, weight loss, coughing, and taste (p < 0.001). Discussion/Conclusion: EC survivors can reach a high global health status and QoL at least 1 year after MIE, despite long-term functional, nutritional, and gastrointestinal complaints. Patients provided written informed consent, and the study protocol was approved by the Ethics Committee of Ghent University Hospital (identifier: ID B670201940737).